Evidence map›Paper›PMID 38890270›Full record

Trial reportTranslational psychiatry2024

Negative emotionality shapes the modulatory effects of ketamine and lamotrigine in subregions of the anterior cingulate cortex.

Matti Gärtner, Anne Weigand, Marvin Sören Meiering, David Weigner, Luisa Carstens, Christian Keicher, Rita Hertrampf, Christian Beckmann, Maarten Mennes, Andreas Wunder and 1 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Translational psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Article
  3. Uncertainty, Not Mental Content, Drives Dorsomedial Prefrontal Engagement during Inferences about Others.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  4. Towards an expanded neurocognitive account of ketamine's rapid antidepressant effects.The international journal of neuropsychopharmacology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Matti GärtnerMedical School Berlin, Berlin, Germany. matti.gaertner@medicalschool-berlin.de.ORCID 0000-0002-1185-1789
Anne WeigandMedical School Berlin, Berlin, Germany.
Marvin Sören MeieringMedical School Berlin, Berlin, Germany.ORCID 0000-0002-9747-5015
David WeignerMedical School Berlin, Berlin, Germany.
Luisa CarstensMedical School Berlin, Berlin, Germany.
Christian KeicherCharité Research Organisation GmbH, Berlin, Germany.ORCID 0000-0002-7552-4082
Rita HertrampfCharité Research Organisation GmbH, Berlin, Germany.
Christian BeckmannSBGneuro Ltd., Oxford, UK.
Maarten MennesSBGneuro Ltd., Oxford, UK.
Andreas WunderTranslational Medicine and Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.
Simone GrimmMedical School Berlin, Berlin, Germany.

Funding

Boehringer Ingelheim na
6 · The paper itself

Abstract

Neuroimaging studies have identified the anterior cingulate cortex (ACC) as one of the major targets of ketamine in the human brain, which may be related to ketamine's antidepressant (AD) mechanisms of action. However, due to different methodological approaches, different investigated populations, and varying measurement timepoints, results are not consistent, and the functional significance of the observed brain changes remains a matter of open debate. Inhibition of glutamate release during acute ketamine administration by lamotrigine provides the opportunity to gain additional insight into the functional significance of ketamine-induced brain changes. Furthermore, the assessment of trait negative emotionality holds promise to link findings in healthy participants to potential AD mechanisms of ketamine. In this double-blind, placebo-controlled, randomized, single dose, parallel-group study, we collected resting-state fMRI data before, during, and 24 h after ketamine administration in a sample of 75 healthy male and female participants who were randomly allocated to one of three treatment conditions (ketamine, ketamine with lamotrigine pre- treatment, placebo). Spontaneous brain activity was extracted from two ventral and one dorsal subregions of the ACC. Our results showed activity decreases during the administration of ketamine in all three ACC subregions. However, only in the ventral subregions of the ACC this effect was attenuated by lamotrigine. 24 h after administration, ACC activity returned to baseline levels, but group differences were observed between the lamotrigine and the ketamine group. Trait negative emotionality was closely linked to activity changes in the subgenual ACC after ketamine administration. These results contribute to an understanding of the functional significance of ketamine effects in different subregions of the ACC by combining an approach to modulate glutamate release with the assessment of multiple timepoints and associations with trait negative emotionality in healthy participants.

Indexed as

EmotionsGyrus CinguliKetamineLamotrigineMagnetic Resonance ImagingAdultAntidepressive AgentsDouble-Blind MethodExcitatory Amino Acid AntagonistsFemaleHumansMaleYoung AdultAntidepressive AgentsExcitatory Amino Acid AntagonistsKetamineLamotrigine

Identifiers

PMID38890270
PMCPMC11189565

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.